The platform can
analyze multiple biomarkers quickly and efficiently, as demonstrated by the fact that a total of 458 plasma samples were analyzed in triplicate, with 23 ELISA analyses per sample - replicate, in a single experiment.
Our panelists will discuss how the ability to
analyze multiple protein
biomarkers is beginning to address some of these challenges, providing potentially important new insights into neurological disorders.